Perfuse Therapeutics is a seed-stage biotechnology company focusing on improving retinal perfusion with a novel mechanism.

Perfuse is developing therapies for several retinal diseases including glaucoma, non-proliferative diabetic retinopathy, and retinal vein occlusion.

‍